Unveiling Novel Arginase Inhibitors for Cutaneous Leishmaniasis Using Drug Repurposing and Virtual Screening Approaches

Documenti analoghi

• Repurposing Non‐Nucleosidic Reverse Transcriptase Inhibitors (NNRTIs) to Overcome EGFR T790M‐Mediated Acquired Resistance in Non‐Small Cell Lung Cancer
  di: Iqrar Ahmad, et al.
  Pubblicazione: (2024)
• Repurposing FDA‐approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach
  di: Kanika Verma, et al.
  Pubblicazione: (2024)
• RETRACTION: Exploring the Effect of Inhibitor AKB‐9778 on VE‐PTP by Molecular Docking and Molecular Dynamics Simulation
  Pubblicazione: (2025)
• Molecular Structure Insights Into Antioxidant, Anti‐Inflammatory, and Computational Investigations: Molecular Docking and Dynamics Studies on Enzyme Inhibitors
  di: Ismail sheriff Parvin, et al.
  Pubblicazione: (2025)
• In Silico Prediction of Potential Inhibitors for Targeting RNA CAG Repeats via Molecular Docking and Dynamics Simulation: A Drug Discovery Approach
  di: Surbhi Singh, et al.
  Pubblicazione: (2024)